![David Lasecki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Lasecki
Plus aucun poste en cours
Historique de carrière de David Lasecki
Anciens postes connus de David Lasecki
Sociétés | Poste | Début | Fin |
---|---|---|---|
CELLECTAR BIOSCIENCES, INC. | Corporate Officer/Principal | 12/04/2022 | 01/11/2022 |
HERON THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
GenomOncology LLC
![]() GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | 29/10/2015 | - |
Formation de David Lasecki
University of Mount Union | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Technology Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
HERON THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
GenomOncology LLC
![]() GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Technology Services |
- Bourse
- Insiders
- David Lasecki
- Expérience